SEARCH

SEARCH BY CITATION

References

  • 1
    Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:7186.
  • 2
    Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995;26:14711477.
  • 3
    He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: A meta-analysis of randomized controlled trials. JAMA 1998;280:19301935.
  • 4
    Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003;34:17101716.
  • 5
    Wani M, Nga E, Navaratnasingham R. Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? Br Med J 2005;331:439442.
  • 6
    Wardlaw JM, Keir SL, Seymour J, et al. What is the best imaging strategy for acute stroke? Health Technol Assess 2004;8:ixiii, 180.
  • 7
    Feigin VL, Anderson N, Rinkel GJE, Algra A, Van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004583. DOI: 10.1002/14651858.CD004583.pub2.
  • 8
    Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006186. DOI: 10.1002/14651858.CD006186.pub2.
  • 9
    Scottish Intercollegiate Guidelines N. SIGN 50: A guideline developers’ handbook. 2004.
  • 10
    Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2007.
  • 11
    Viswanathan A, Rakich SM, Engel C, et al. Antiplatelet use after intracerebral hemorrhage. see comment. Neurology 2006;66:206209.
  • 12
    Claassen DO, Kazemi N, Zubkov AY, Wijdicks EFM, Rabinstein AA. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol 2008;65:13131318.
  • 13
    Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: A 2-year follow-up. Br J Haematol 1998;103:10641066.
  • 14
    Butler A, Tait RC. Restarting oral anticoagulation after intracranial hemorrhage. Stroke 2004;35:e5e6.
  • 15
    Butler AC, Tait RC. Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev 1998;12:3544.
  • 16
    Nakagawa T, Kubota T, Handa Y, Kawano H, Sato K. Intracranial hemorrhage due to long-term anticoagulant therapy in patients with prosthetic heart valves—four case reports. Neurol Med Chir (Tokyo) 1995;35:156159.
  • 17
    Nagano N, Tabata H, Hashimoto K. Anticoagulant-related intracerebral hemorrhage in patients with prosthetic heart valves—report of two cases. Neurol Med Chir (Tokyo) 1991;31:743745.
  • 18
    Lau CP, Chang CM, Lau GK, Wong CK, Fong PC, Yu YL. Cerebral haemorrhage in anticoagulated patients with non-septic mechanical valvular prosthesis. Int J Cardiol 1991;30:289296.
  • 19
    Babikian VL, Kase CS, Pessin MS, Caplan LR, Gorelick PB. Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves. Stroke 1988;19:407408.
  • 20
    Punthakee X, Doobay J, Anand SS. Oral-anticoagulant-related intracerebral hemorrhage. Thromb Res 2002;108:3136.
  • 21
    Gomez CR, Sandhu J, Mehta P. Resumption of anticoagulation during hypertensive cerebral hemorrhage with prosthetic heart valve. Stroke 1988;19:407.
  • 22
    Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 1995;44:438442.
  • 23
    Leker RR, Abramsky O. Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. see comment. Neurology 1998;50:14891491.
  • 24
    Bertram M, Bonsanto M, Hacke W, Schwab S. Managing the therapeutic dilemma: Patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol 2000;247:209214.
  • 25
    Wijdicks EF, Schievink WI, Brown RD, Mullany CJ. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 1998;42:769773.
  • 26
    Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. see comment. Arch Neurol 2000;57:17101713.
  • 27
    Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: A historical cohort study. Arch Phys Med Rehabil 2004;85:10701075.
  • 28
    De Vleeschouwer S, Van Calenbergh F, Van Loon J, Nuttin B, Goffin J, Plets C. Risk analysis of thrombo-embolic and recurrent bleeding events in the management of intracranial haemorrhage due to oral anticoagulation. Acta Chir Belg 2005;105:268274.
  • 29
    Hakim AM, Ryder-Cooke A, Melanson D. Sequential computerized tomographic appearance of strokes. Stroke 1983;14:893897.
  • 30
    Lodder J, Van Der Lugt PJ. Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. Stroke 1983;14:4246.
  • 31
    Pessin MS, Estol CJ, Lafranchise F, Caplan LR. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993;43:12981303.
  • 32
    Ott BR, Zamani A, Kleefield J, Funkenstein HH. The clinical spectrum of hemorrhagic infarction. Stroke 1986;17:630637.
  • 33
    Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group. Stroke 1984;15:779789.
  • 34
    Chaves CJ, Pessin MS, Caplan LR, et al. Cerebellar hemorrhagic infarction. Neurology 1996;46:346349.
  • 35
    Ananthasubramaniam K, Beattie JN, Rosman HS, Jayam V, Borzak S. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 2001;119:478484.
  • 36
    Lieberman A, Hass WK, Pinto R, et al. Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves. Stroke 1978;9:1824.
  • 37
    White RH, McKittrick T, Takakuwa J, Callahan C, McDonell M, Fihn S. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics. Arch Intern Med 1996;156:11971201.
  • 38
    Toyoda K, Yasaka M, Iwade K, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: A prospective, multicenter, observational study. Stroke 2008;39:17401745.
  • 39
    Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EFM, Rabinstein AA. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol 2008;65:13201325.
  • 40
    Tetri S, Mäntymäki L, Juvela S, et al. Impact of ischemic heart disease and atrial fibrillation on survival after spontaneous intracerebral hemorrhage. J Neurosurg 2008;108:11721177.
  • 41
    Wikholm G, Lindgren H, Rodriguez M, Elfverson J. Embolisation with Guglielmi detachable coils during the period of increased risk for cerebral vasospasm: Early outcome. Neuroradiology 2000;42:833837.
  • 42
    Necioglu Orken D, Kenangil G, Guner C, Celik M, Forta H. Heparin treatment for the proflaxis of deep venous thrombosis in the subacute stage of intracerebral hemorrhages. Turk Serebrovaskuler Hastaliklar Dergisi 2007;13:3739.
  • 43
    Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clin Proc 2007;82:8292.
  • 44
    Goldstein LB. Primum non nocere: Antithombotics after intracerebral hemorrhage? Neurology 2006;66:162163.
  • 45
    Alberts MJ. Do antiplatelet agents increase the risk of recurrent intracerebral hemorrhage? Nat Clin Pract Neuro 2006;2:480481.
  • 46
    Hill MD. Is antiplatelet therapy safe after intracerebral hemorrhage? Nat Clin Pract Card 2006;3:298299.
  • 47
    Estol CJ, Kase CS. Need for continued use of anticoagulants after intracerebral hemorrhage. Curr Treat Options Cardiovasc Med 2003;5:201209.
  • 48
    Scottish Intercollegiate Guidelines Network. SIGN 108. Management of patients with stroke or TIA: Assessment, investigation, immediate management and secondary prevention. A national clinical guideline. Edinburgh : Scottish Intercollegiate Guidelines Network, 2008.
  • 49
    Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831841.
  • 50
    Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 Update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007;116:e391e413.
  • 51
    Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 2007;68:116121.
  • 52
    Ariesen MJ, Claus SP, Rinkel GJE, Algra A. Risk factors for Intracerebral Hemorrhage in the general population: A systematic review. Stroke 2003;34:20602065.
  • 53
    Sturgeon JD, Folsom AR, Longstreth WT Jr., Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke 2007;38:27182725.
  • 54
    Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr., Folsom AR. Risk factors for ischemic stroke subtypes: The Atherosclerosis Risk in Communities Study. Stroke 2006;37:24932498.
  • 55
    Hennekens CH, Buring JE, Mayrent SL. Epidemiology in medicine. Boston : Little, Brown ; 1987.
  • 56
    Vandenbroucke JP. Case reports in an evidence-based world. J R Soc Med 1999;92:159163.
  • 57
    Hacke W. The dilemma of reinstituting anticoagulation for patients with cardioembolic sources and intracranial hemorrhage: How wide is the strait between Skylla and Karybdis? comment. Arch Neurol 2000;57:16821684.